NCT02171208View on ClinicalTrials.gov

A Healthy Volunteer Study to Establish the Bioequivalence of BG00012 Supplied by 2 Different Commercial Manufacturers

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Healthy
Interventions
DRUG

dimethyl fumarate - Reference form

single dose 240 mg

DRUG

dimethyl fumarate - Test form

single dose 240 mg

Trial Locations (2)

32117

Research Site, Daytona Beach

47710

Research Site, Evansville

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY